4.4 out of 5 stars
(48 Ratings)
FrameworkLTC's fully integrated and scalable platform automates all manual tasks, allowing LTC pharmacies to focus on what is most important: improving patient lives. Automation replaces manual tasks and allows you to expand your business while maximising margins. Delivering services that meet the needs of each facility will strengthen your partner relationships. Our facility-centric software allows you to provide concierge-level service, catering to every patient, wing, and facility. Allow facilities to print bills, check order statuses, and process returns according to your pre-defined rules. Your facilities will appreciate your reports. Automate refill and reorder prescriptions so they don't get lost on the production floor.
Learn more about FrameworkLTC
4.8 out of 5 stars
(30 Ratings)
JDisc Discovery is a powerful IT asset management and network discovery tool, designed to provide organizations with clear, real-time insights into their entire IT environment. By automatically scanning the network, it identifies and catalogs devices, from physical servers and workstations to virtual machines and network appliances, giving users a detailed inventory of their assets. The tool captures essential data such as hardware specifications, installed software, system configurations, and interdependencies among devices.
A key advantage of JDisc Discovery is its agentless architecture. Rather than requiring installation on each device, it uses multiple protocols (like SNMP, SSH, WMI) to gather information, ensuring quick deployment and compatibility across various operating systems, including Windows, Linux, and Unix. This makes it ideal for diverse and dynamic IT ecosystems, enabling efficient and non-intrusive data collection.
Learn more about JDisc Discovery
GPT-Rosalind
GPT-Rosalind is an advanced reasoning model created by OpenAI, aimed at enhancing scientific exploration in fields like biology, drug development, and translational medicine. Tailored for workflows in life sciences, it assists researchers in managing extensive literature, experimental findings, and specialized databases to formulate and test innovative concepts. By integrating a profound understanding of disciplines such as chemistry, genomics, protein engineering, and disease biology with sophisticated tool-usage capabilities, it effectively interacts with scientific databases, examines experimental results, and facilitates intricate, multi-stage reasoning tasks. Its functionalities span evidence synthesis, hypothesis formulation, literature assessment, sequence analysis, and experimental design, empowering scientists to transition more swiftly from raw data to meaningful insights. Furthermore, GPT-Rosalind revolutionizes cumbersome, time-consuming research methodologies into streamlined, AI-enhanced workflows, ultimately fostering a more productive scientific environment. This model exemplifies the fusion of artificial intelligence with scientific inquiry, paving the way for groundbreaking discoveries.
Learn more about GPT-Rosalind
Recursion
Recursion is a leading TechBio innovator using artificial intelligence to radically improve how new medicines are discovered and developed. The company was founded on the idea that images of cells could be used to train AI systems to understand disease biology at scale. By combining data, machine learning models, and powerful computing, Recursion works to overcome the inefficiencies of traditional drug discovery. Its Recursion OS platform connects massive proprietary biological datasets with automated experimentation and AI-driven insights. This approach has produced a growing pipeline of potential therapies for oncology and rare diseases with high unmet medical needs. Recursion has demonstrated significant gains in speed, efficiency, and cost reduction compared to conventional pharmaceutical methods. Strategic partnerships with pharmaceutical companies and technology leaders expand the reach of its platform. The company also collaborates with NVIDIA to power its discovery efforts using BioHive-2, one of the most advanced supercomputers in biopharma. Together, these capabilities position Recursion as a leader in AI-driven drug discovery. Its ultimate goal is to deliver better medicines to patients through precision design and data-driven science.
Learn more about Recursion